TP53 co-mutations in EGFR mutated patients in NSCLC stage IV: A strong predictive factor of ORR, PFS and OS in EGFR mt+ NSCLC

por Roeper, Julia, Falk, Markus, Chalaris-Rißmann, Athena, Lueers, Anne C., Ramdani, Hayat, Wedeken, Katrin, Stropiep, Ursula, Diehl, Linda, Tiemann, Markus, Heukamp, Lukas C., Otto-Sobotka, Fabian, Griesinger, Frank
Publicado 2020